0.80
price down icon0.74%   -0.006
pre-market  Pre-market:  .77   -0.03   -3.75%
loading
Durect Corp stock is traded at $0.80, with a volume of 12,918. It is down -0.74% in the last 24 hours and up +2.79% over the past month.
See More
Previous Close:
$0.806
Open:
$0.8151
24h Volume:
12,918
Relative Volume:
0.19
Market Cap:
$25.02M
Revenue:
$8.59M
Net Income/Loss:
$-17.07M
P/E Ratio:
-1.3115
EPS:
-0.61
Net Cash Flow:
$-21.90M
1W Performance:
-5.77%
1M Performance:
+2.79%
6M Performance:
-38.93%
1Y Performance:
-33.88%
1-Day Range:
Value
$0.80
$0.8151
1-Week Range:
Value
$0.80
$0.849
52-Week Range:
Value
$0.701
$1.88

Durect Corp Stock (DRRX) Company Profile

Name
Name
Durect Corp
Name
Phone
(408) 777-1417
Name
Address
10240 BUBB ROAD, CUPERTINO, CA
Name
Employee
0
Name
Twitter
@DURECTCorp
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
DRRX's Discussions on Twitter

Compare DRRX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
DRRX
Durect Corp
0.80 25.02M 8.59M -17.07M -21.90M -0.61
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
163.11 73.07B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.05 47.43B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.24 45.72B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
15.08 17.28B 16.54B -1.64B 749.00M -1.45
Biotechnology icon
UTHR
United Therapeutics Corp
306.97 14.37B 2.76B 1.11B 898.10M 22.77

Durect Corp Stock (DRRX) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-30-20 Initiated Chardan Capital Markets Buy
Oct-12-20 Initiated ROTH Capital Buy
Jul-31-20 Initiated Oppenheimer Outperform
Jan-31-20 Initiated B. Riley FBR Buy
Nov-18-19 Resumed Cantor Fitzgerald Overweight
Sep-06-19 Initiated Cantor Fitzgerald Overweight
Mar-06-18 Upgrade H.C. Wainwright Neutral → Buy
Oct-20-17 Downgrade H.C. Wainwright Buy → Neutral
Oct-20-17 Reiterated Laidlaw Buy
Oct-20-17 Downgrade Stifel Buy → Hold
Jul-12-17 Upgrade Stifel Hold → Buy
Feb-28-17 Resumed H.C. Wainwright Buy
Apr-25-16 Initiated Rodman & Renshaw Buy
May-01-15 Reiterated Cantor Fitzgerald Buy
May-01-15 Reiterated Stifel Buy
Mar-25-13 Initiated Stifel Buy
Nov-01-12 Downgrade C.K. Cooper Buy → Hold
Aug-17-12 Initiated C.K. Cooper Buy
Jun-23-09 Initiated Caris & Company Buy
Mar-26-09 Initiated Wedbush Morgan Hold
View All

Durect Corp Stock (DRRX) Latest News

pulisher
Mar 28, 2025

DURECT Corporation (NASDAQ:DRRX) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 28, 2025
pulisher
Mar 28, 2025

Here's Why We're A Bit Worried About DURECT's (NASDAQ:DRRX) Cash Burn Situation - Yahoo Finance

Mar 28, 2025
pulisher
Mar 27, 2025

DURECT Corporation’s Earnings Call Highlights Cost Cuts and Breakthrough Potential - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

Durect Corp Q4 2024 Earnings: EPS of $0.25 Surpasses Estimates, Revenue Falls Short at $0.5 Million - GuruFocus.com

Mar 27, 2025
pulisher
Mar 27, 2025

Durect Corp (DRRX) Q4 2024 Earnings Call Highlights: Strategic Focus Amid Financial Challenges - Yahoo Finance

Mar 27, 2025
pulisher
Mar 27, 2025

Durect Corp (DRRX) Q4 2024 Earnings Call Highlights: Strategic F - GuruFocus.com

Mar 27, 2025
pulisher
Mar 26, 2025

Durect: Q4 Earnings Snapshot - mySA

Mar 26, 2025
pulisher
Mar 26, 2025

Durect reports Q4 cont ops EPS (6c), consensus (2c) - TipRanks

Mar 26, 2025
pulisher
Mar 26, 2025

Durect (DRRX) Reports Q4 Loss, Lags Revenue Estimates - MSN

Mar 26, 2025
pulisher
Mar 26, 2025

Earnings call transcript: Durect’s Q4 2024 revenue drops as focus shifts to key drug - Investing.com India

Mar 26, 2025
pulisher
Mar 26, 2025

DURECT Corp reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 26, 2025
pulisher
Mar 26, 2025

DURECT Transforms Business: $17.5M Asset Sale, NEJM Evidence Validates Key Drug Program - StockTitan

Mar 26, 2025
pulisher
Mar 26, 2025

Earnings Scheduled For March 26, 2025 - Benzinga

Mar 26, 2025
pulisher
Mar 25, 2025

What To Expect From Durect Corp (DRRX) Q4 2024 Earnings - GuruFocus.com

Mar 25, 2025
pulisher
Mar 19, 2025

DURECT Corporation to Announce Fourth Quarter and Full Year 2024 - GuruFocus.com

Mar 19, 2025
pulisher
Mar 19, 2025

DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update - Quantisnow

Mar 19, 2025
pulisher
Mar 19, 2025

DURECT (DRRX) to Release Quarterly Earnings on Wednesday - Defense World

Mar 19, 2025
pulisher
Mar 19, 2025

DURECT Q4 Earnings Preview: Key Financial Results and Strategic Updates Coming March 26 - StockTitan

Mar 19, 2025
pulisher
Mar 19, 2025

StockNews.com Begins Coverage on DURECT (NASDAQ:DRRX) - Defense World

Mar 19, 2025
pulisher
Mar 15, 2025

DURECT Corporation (NASDAQ:DRRX) Is Expected To Breakeven In The Near Future - Simply Wall St

Mar 15, 2025
pulisher
Mar 07, 2025

Wnt efforts condensing at Dewpoint, Surrozen, more - BioWorld Online

Mar 07, 2025
pulisher
Mar 06, 2025

Larsucosterol flops on clinical benefit in phase 2b alcohol-associated hepatitis trial - Healio

Mar 06, 2025
pulisher
Mar 03, 2025

DURECT (NASDAQ:DRRX) Earns Sell Rating from Analysts at StockNews.com - Defense World

Mar 03, 2025
pulisher
Feb 26, 2025

The R&D Dept.: Local patent roundup for 2.26.25 - RichmondBizSense

Feb 26, 2025
pulisher
Feb 15, 2025

DURECT (NASDAQ:DRRX) Coverage Initiated at StockNews.com - Defense World

Feb 15, 2025
pulisher
Feb 10, 2025

DURECT (NASDAQ:DRRX) Research Coverage Started at StockNews.com - Defense World

Feb 10, 2025
pulisher
Feb 04, 2025

DURECT Corporation to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference - Yahoo Finance

Feb 04, 2025
pulisher
Feb 04, 2025

Exclusive Healthcare Conference Alert: DURECT CEO Reveals Latest Developments - StockTitan

Feb 04, 2025
pulisher
Jan 30, 2025

StockNews.com Initiates Coverage on DURECT (NASDAQ:DRRX) - Defense World

Jan 30, 2025
pulisher
Jan 28, 2025

DURECT Corporation Announces Publication of Larsucosterol Phase 2b Results in NEJM Evidence - Stockhouse Publishing

Jan 28, 2025
pulisher
Jan 22, 2025

DURECT (NASDAQ:DRRX) Coverage Initiated by Analysts at StockNews.com - Defense World

Jan 22, 2025
pulisher
Jan 16, 2025

Durect (DRRX) Upgraded to Strong Buy: Here's Why - Yahoo Finance

Jan 16, 2025
pulisher
Jan 13, 2025

Geode Capital Management LLC Has $429,000 Holdings in DURECT Co. (NASDAQ:DRRX) - Defense World

Jan 13, 2025
pulisher
Jan 11, 2025

DURECT faces Nasdaq delisting over share price - Investing.com

Jan 11, 2025
pulisher
Jan 09, 2025

New Strong Buy Stocks for January 9th - Yahoo Finance

Jan 09, 2025
pulisher
Dec 27, 2024

Reviewing Acerus Pharmaceuticals (OTCMKTS:TRLPF) and DURECT (NASDAQ:DRRX) - Defense World

Dec 27, 2024
pulisher
Dec 16, 2024

Microbial Products Market Size to Hit USD 351.42 Bn by 2034 - Precedence Research

Dec 16, 2024
pulisher
Dec 11, 2024

Durect (DRRX) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Dec 11, 2024
pulisher
Dec 02, 2024

DURECT Corp expected to post a loss of 17 cents a shareEarnings Preview - XM

Dec 02, 2024
pulisher
Nov 28, 2024

Is BellRing Brands (BRBR) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Nov 28, 2024
pulisher
Nov 26, 2024

DURECT Corp sells ALZET product line to Lafayette - TradingPedia

Nov 26, 2024
pulisher
Nov 25, 2024

Durect announces sale of Alzet line of osmotic pumps to LIC for $17.5M - TipRanks

Nov 25, 2024
pulisher
Nov 25, 2024

DURECT Corporation Announces Sale of ALZET® Product Line to Lafayette Instrument Co. for $17.5 Million - PR Newswire

Nov 25, 2024
pulisher
Nov 15, 2024

DURECT Corporation (NASDAQ:DRRX) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024
pulisher
Nov 14, 2024

Earnings call: DURECT Corporation reports Q3 2024 financials - Investing.com

Nov 14, 2024
pulisher
Nov 14, 2024

Durect Corp (DRRX) Q3 2024 Earnings Call Highlights: Revenue Gro - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Durect Corp (DRRX) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Cost Reductions and ... - Yahoo Finance

Nov 14, 2024
pulisher
Nov 14, 2024

Durect Corp (DRRX) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Cost Reductions and ... By GuruFocus - Investing.com Canada

Nov 14, 2024
pulisher
Nov 14, 2024

Durect: Q3 Earnings Snapshot - Houston Chronicle

Nov 14, 2024
pulisher
Nov 13, 2024

Durect Corp Q3 2024 Earnings: GAAP EPS of -$0.14 Misses Estimates, Revenue at $1.9 Million Below Expectations - GuruFocus.com

Nov 13, 2024

Durect Corp Stock (DRRX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$33.21
price down icon 0.95%
$96.16
price down icon 0.91%
$8.68
price down icon 1.81%
$113.16
price down icon 0.74%
$131.81
price up icon 0.05%
$306.97
price down icon 0.34%
Cap:     |  Volume (24h):